Morning Release of 27 Sep, 2017.

Indian shares ended lower for their sixth straight session on Tuesday, as continued tensions on the Korean Peninsula kept investors cautious. The benchmark BSE index fell 0.08% to 31,599.76, while the broader NSE index fell 0.01% to 9,871.50. The NSE index posted its longest losing streak in nearly three months, while the BSE index posted its longest falling run in nine months.

Consumer goods maker, Hindustan Unilever Ltd. and mortgage lender, Housing Development Finance Corp were among the stocks that contributed maximum losses to the indices.

Top Gainers

Company Name	Close	% Change
VEDL	317.65	3.54%
ONGC	170.30	3.34%
IBULHSGFIN	1,239.50	2.95%

Top Losers

Company Name	Close	% Change
BPCL	468.50	-3.83%
INFRATEL	376.40	-3.82%
TATAPOWER	79.85	-2.44%

52 week High & Low

Company Name	Close	High or Low?
ANIKINDS	67.10	HIGH
AIFL	516.95	HIGH
8KMILES	368.00	LOW
ADHUNIKIND	57.00	LOW

Indices

Indices	Last Trade	% Change
NIFTY	9,871.50	-0.01%
NIFTY IT	10,548.50	-0.19%
NIFTY PHARMA	9,297.90	0.01%
NIFTY FMCG	24,872.10	-0.43%
NIFTY REALTY	271.50	-4.53%
BANK NIFTY	24,199.15	0.14%
INDIA VIX	12.92	-3.09%

FII/DII Activity as on 26 Sep, 2017

FII/DII	Net Change (in Cr.)
FII	-1,915.54
DII	1,537.10

Corporate Events

• Thyssenkrupp raised almost 1.4 billion euros ($1.7 billion) in a share to help fund the industrial goods businesses that will stay with the firm after the planned merger of its steel operations with Tata Steel next year.
  
• Dabur and Amazon announced a partnership to launch ayurveda online.
  
• Drug price regulator, NPPA has said Abbott Healthcare has been allowed to withdraw THE latest drug eluting stent, Xience Alpine from the Indian market with the Department of Pharmaceuticals not approving its request to block the move.

Results Corner

• Advertisement Standards Council of India (ASCI), the apex body to regulate advertisements to promote fair competition, has rejected Hindustan Unilever's (HUL) objection to the Emami campaign for its Fair & Handsome mens fairness brand variants.
  
• Drug firm, Vivimed Labs has signed definitive agreements with healthcare firm, OrbiMed Asia for investment of USD 42.5 million (nearly INR. 277 Cr.) in its subsidiary, Vivimed Labs Mascarene Ltd.

Outlook

Nifty failed to break the resistance for the sixth consecutive session and closed at 9871.50 with a change of –0.01%. Nifty is expected to open flattish with holding an upside resistance of 9920 and immediate support level of 9835.